.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021065

« Back to Dashboard
NDA 021065 describes FEMHRT, which is a drug marketed by Apil and is included in one NDA. It is available from three suppliers. Additional details are available on the FEMHRT profile page.

The generic ingredient in FEMHRT is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.

Summary for NDA: 021065

Tradename:
FEMHRT
Applicant:
Apil
Ingredient:
ethinyl estradiol; norethindrone acetate
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 021065

Ingredient-typeProgesterone Congeners
Mechanism of ActionEstrogen Receptor Agonists

Suppliers and Packaging for NDA: 021065

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FEMHRT
ethinyl estradiol; norethindrone acetate
TABLET;ORAL 021065 NDA Warner Chilcott (US), LLC 0430-0145 0430-0145-14 5 POUCH in 1 CARTON (0430-0145-14) > 1 BLISTER PACK in 1 POUCH > 28 TABLET in 1 BLISTER PACK
FEMHRT
ethinyl estradiol; norethindrone acetate
TABLET;ORAL 021065 NDA Actavis Pharma, Inc. 52544-236 52544-236-31 3 POUCH in 1 CARTON (52544-236-31) > 1 BLISTER PACK in 1 POUCH > 28 TABLET in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.0025MG;0.5MG
Approval Date:Jan 14, 2005TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.005MG;1MG
Approval Date:Oct 15, 1999TE:RLD:No

Expired Orange Book Patents for NDA: 021065

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apil
FEMHRT
ethinyl estradiol; norethindrone acetate
TABLET;ORAL021065-001Jan 14, 20055,208,225► subscribe
Apil
FEMHRT
ethinyl estradiol; norethindrone acetate
TABLET;ORAL021065-002Oct 15, 19995,208,225► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc